The stock of The Clorox Company (NYSE:CLX) decreased by -$4.26 on Tuesday to finish at $138.44, down -2.99 percent. The last five days have seen an average of 1,799,420 shares of common stock traded. 17 times new highs were reached in the current year, with a fall of -$1.89. The average number of shares traded over the last 20 days was 1,214,305, while the average volume over the last 50 days totaled 1,269,458.
CLX stock dropped -10.02% since last month. On 09/19/23, the company’s shares reached a one-month low of $138.02. The stock touched a high of $178.21 on 05/03/23, after rallying from a low of $124.58 in 52 weeks. The price of CLX stock has declined by -1.35% or -$1.89 this year, reaching a new high 17 times. Still, the stock price is down -22.31% from the 52-week high.
Insider Transactions
CLX stock investors should be aware that The Clorox Company (CLX) stock had its last reported insider trading activity 37 days ago on Aug 14. On Aug 14, EVP – Chief Financial Officer Jacobsen Kevin B sold 3,346 shares at $160.82 each. This transaction resulted in the insider making $538,096.
Valuation Metrics
The Clorox Company (CLX) has a trailing price-to-earnings (P/E) ratio of 118.02. Beta for the stock is 0.27. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 2.37, the price-to-book (PB) ratio of 77.78, and the price-to-cash flow ratio of 18.84.
Company paid $1.20 per share in dividends, an increase of 1.69% from $1.18 last year. A $0.02 dividend increase was reported on Thursday July 27 2023.
Financial Health
For the three months ended June 29, The Clorox Company’s quick ratio was 0.60, while its current ratio was 1.00, indicating its inability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 11.26, and the total debt to equity ratio is 11.49. As far as profitability goes, gross margin for the trailing twelve months is 39.30% percent. The Clorox Company’s operating margin stood at 3.20% for the same period. Based on annual data, it had gross profit of $2.91 billion and revenue of $7.39 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. CLX’s return on assets (ROA) during the last 12 months has been 2.50%. There was a 5.80% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 68.50%.
Earnings Surprise
According to The Clorox Company’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $2.02 billion, while revenues rose by 10.8% to $1.92 billion. It was predicted that The Clorox Company’s quarterly earnings would be $1.67, but it ended up being $1.18, beating the consensus by 41.50%. EBITDA was $346.0 million for the quarter. At the end of The Clorox Company’s most recent quarter ended June 29, its liabilities totaled 5.56 billion, while its total debt was $2.95 billion. Equity owned by shareholders amounts to $123.83 million.
Technical Picture
Here’s a quick look at The Clorox Company’s (CLX) price momentum from a technical perspective. As of 19 September, the RSI 9-day stood at 18.74%, suggesting the stock is oversold, with a 24.14% historical volatility rate.
The stochastic %K and %D were 2.87% and 7.23% respectively, while the average true range (ATR) was 3.24. Based on the 14-day stochastic reading of 2.03%, the RSI (14) reading is 24.94%. On the 9-day MACD Oscillator, the stock is at -6.27, and the 14-day reading is at -8.57.
Analyst Ratings
In its most recent analyst report, Atlantic Equities raised its rating on The Clorox Company (NYSE: CLX) to a Neutral. Prior to this, analysts firm rated the stock as an Underweight. Analysts have assigned The Clorox Company (CLX) an Underweight rating. CLX is a stock that is recommended for selling by 6 brokerage firms, while 9 companies recommend holding. The stock is underweighted by 2 analysts. Among the analysts who rate the stock, 2 rates it overweight and 1 other recommend it as a buy.
What is CLX’s price target for the next 12 months?
The current consensus forecast for the stock is between $127.00 and $185.00, with a median target price of $152.00. In analyzing these forecasts, the average price target given by analysts for The Clorox Company (CLX) is $155.35.
